Inventor
LIANG XIFU
DK17 patents
⚠️ This page may combine multiple inventors who share the name “LIANG XIFU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LEO PHARMA AS
7 patentsUS11065257B2Jul 20, 2021
Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors
LEO PHARMA AS3 citations72
US10906915B2Feb 2, 2021
Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors
LEO PHARMA AS3 citations72
US10793580B2Oct 6, 2020
Substituted pyrazoloazepin-8-ones and their use as phosphodiesterase inhibitors
LEO PHARMA AS3 citations71
US7034015B2Apr 25, 2006
Aminobenzoephenones
LEO PHARMA AS6 citations61
US11377425B1Jul 5, 2022
Small molecule modulators of IL-17
LEO PHARMA AS1 citations57
US8350026B2Jan 8, 2013
VEGF-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof
LEO PHARMA AS1 citations46
US7977387B2Jul 12, 2011
Aminobenzophenone compounds
LEO PHARMA AS0 citations33
LEO LABORATORIES LTD
6 patentsUS9676698B2Jun 13, 2017
Method of producing ingenol-3-angelate
LEO LABORATORIES LTD4 citations70
US9416084B2Aug 16, 2016
Method of producing ingenol-3-angelate
LEO LABORATORIES LTD4 citations70
US9422309B2Aug 23, 2016
3-O-heteroaryl-ingenol
LEO LABORATORIES LTD2 citations57
US9624157B2Apr 18, 2017
Process for the preparation of ingenol-3-angelate from 20-deoxy-ingenol
LEO LABORATORIES LTD0 citations50
US9708286B2Jul 18, 2017
Ingenol-3-acylates III and ingenol-3-carbamates
LEO LABORATORIES LTD0 citations46
US9404131B2Aug 2, 2016
Process for the preparation of ingenol-3-angelate
LEO LABORATORIES LTD0 citations42